Skip to main content
×
×
Home
  • Print publication year: 2013
  • Online publication date: March 2013

40 - Rubella

from Section 6 - Viral Infections
Summary

Rubella or ‘little red’ is one of six classic childhood illnesses characterized by fever and a rash. It is a mild febrile illness of little direct clinical importance. It has a world-wide distribution and tends to occur in epidemics. Its main relevance is when infection occurs during the first trimester of pregnancy, when there is a high incidence of serious congenital abnormalities (WHO, 1999). This can be prevented by vaccination and, since man is the only known host, it is theoretically possible to eliminate the disease.

The problem in Africa

Rubella is not yet included in the childhood immunization strategy of any sub-Saharan country. Two-thirds of young adults have been exposed, and congenital rubella syndrome (CRS) continues to be an important and under-recognized problem, affecting 0.1–0.2 per 1000 live births (Clarke et al., 1980; Cutts et al., 1997).

Biology

Rubella is caused by a single-stranded RNA virus from the Togaviridae family, which consists of a capsid and an envelope protein with only one antigenic strain. It is transmitted by airborne droplets but can also be passed on by direct contact with recently contaminated material. Viral shedding from the upper respiratory tract begins around 10 days after infection and the incubation period is 2–3 weeks. Patients are considered to be infectious from 1 week before to 1 week after onset of the rash, and children should be excluded from school and avoid contact with pregnant women during this time. Rubella is inactivated by ultraviolet light, 1 per cent sodium hypochlorite and 70 per cent ethanol (WHO, 2007).

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Principles of Medicine in Africa
  • Online ISBN: 9780511751660
  • Book DOI: https://doi.org/10.1017/CBO9780511751660
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×
References
Best, JM, O'Shea, S, Tipples, G et al. (2002). Interpretation of rubella serology in pregnancy – pitfalls and problems. BMJ 325: 147–8.
Clarke, M, Schild, GC, Boustred, J et al. (1980). Epidemiological studies of rubella virus in a tropical African community. Bull Wld Hlth Org; 58: 931–5.
Cutts, FT, Robertson, SE, Diaz-Ortega, J-L et al. (1997). Control of rubella and congenital rubella syndrome (CRS) in developing countries part 1: burden of disease from CRS. Bull Wrld Hlth Org; 75: 55–68.
Helfand, RF, Keyserling, HL, Williams, I et al. (2001). Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J Med Virol; 65: 751–7.
Miller, E, Cradock-Watson, JE, Pollock, TM (1982). Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet; 2: 781–4.
Morbidity and mortality weekly report (1989). Rubella vaccination during pregnancy – United States, 1971–1988. MMWR; 38: 289–93.
Panagiotopoulos, T, Antoniadou, I, Valassi-Adam, E (1999). Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ; 319: 1462–6.
Robertson, CM, Bennett, VJ, Jefferson, N et al. (1988). Serological evaluation of a measles, mumps and rubella vaccine. Arch Dise Childh; 63: 612–16.
World Health Organization (1999). Guidelines for surveillance of congenital rubella syndrome (CRS) and rubella – Field test version. Geneva: WHO.
World Health Organization (2000) Control of rubella and congenital rubella syndrome in developing countries. Geneva: WHO.
World Health Organization (2007). Manual for the laboratory diagnosis of measles and rubella virus infection. 2nd edn. Geneva: WHO.